MDP — Medcamp SA Share Price
Last trade - 00:00- PLN20.92m
- PLN18.33m
- 19
- 17
- 64
- 21
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.02 | ||
| Price to Tang. Book | 6.02 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -5.28% | ||
| Return on Equity | 42.34% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | PLNm | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medcamp SA, formerly T2 Investment SA, is a Poland-based company engaged in the real estate operations. The Company is involved in the acquisition, management, redevelopment and upgrade, as well as rental and sale of commercial properties, including office areas and warehouses. In addition, the Company is involved in long-term investments in construction and real estate entities. It conducts rental and redevelopment projects, such as Poznan, Jasielska; Poznan, Komorniki; Poznan, Jasielska, Inkubator; Szamotuly, Dworcowa; among others. The Company aims to build a research and development center in Poznan, specializing in such areas as personalized medicine, genetics, genomics and bioinformatics, supported by artificial intelligence, The Company operates through subsidiaries, including T2 Inkubator Sp z o o, T2 Szamotuly Sp z o o, Polskie Centrum Badan i Rozwoju Sp z o o, among others. The majority shareholder of the Company is Moonrock Enterprise SA.
Directors
- Cezary Ziarkowski CMG
- Andrzej Dulnik SEC
- Tomasz Banasiewicz SUB
- Bogdan Kasprzyk SUB
- Mariusz Koitka SUB
- Dariusz Kojat SUB
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 16th, 2007
- Public Since
- November 16th, 2007
- Sector
- Real Estate Operations
- Industry
- Financials
- Exchange
- Warsaw Stock Exchange
- Shares in Issue
- 26,150,000
- Address
- ul. Jeleniogorska 16 C/3, POZNAN, 60-179
- Web
- https://medcampsa.pl/
- Phone
- +48 616648000
- Auditors
- FEHU GLOBAL AUDYT Sp. z o.o.
Upcoming Events for MDP
Similar to MDP
Alta SA
Warsaw Stock Exchange
Bbi Development SA
Warsaw Stock Exchange
CPD SA
Warsaw Stock Exchange
City Service SE
Warsaw Stock Exchange
Clean&Carbon Energy SA
Warsaw Stock Exchange
FAQ
As of Today at 21:58 UTC, shares in Medcamp SA are trading at PLN0.80. This share price information is delayed by 15 minutes.
Shares in Medcamp SA last closed at PLN0.80 and the price had moved by +48.28% over the past 365 days. In terms of relative price strength the Medcamp SA share price has outperformed the FTSE Global All Cap Index by +44.56% over the past year.
There is no consensus recommendation for this security.
Find out moreMedcamp SA does not currently pay a dividend.
Medcamp SA does not currently pay a dividend.
Medcamp SA does not currently pay a dividend.
To buy shares in Medcamp SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN0.80, shares in Medcamp SA had a market capitalisation of PLN20.92m.
Here are the trading details for Medcamp SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: MDP
Based on an overall assessment of its quality, value and momentum Medcamp SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medcamp SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +71.78%.
As of the last closing price of PLN0.80, shares in Medcamp SA were trading +22.32% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medcamp SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at PLN0.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medcamp SA's management team is headed by:
- Cezary Ziarkowski - CMG
- Andrzej Dulnik - SEC
- Tomasz Banasiewicz - SUB
- Bogdan Kasprzyk - SUB
- Mariusz Koitka - SUB
- Dariusz Kojat - SUB